BERYL DRUGS LTD.
BSE: 524606
values in crores
Revenue & Profit Trend
in croresRevenueExpenditureNet Profit
Margin Trend
percentageOPM %NPM %
| Period | Q4 FY2026 | Q3 FY2026 | Q2 FY2026 | Q1 FY2026 | Q4 FY2025 | Q3 FY2025 | Q2 FY2025 |
|---|---|---|---|---|---|---|---|
| INCOME | |||||||
| Revenue | 5.13+35.8% | 3.78-26.2% | 5.12+6.8% | 4.79+20.7% | 3.97-25.2% | 5.31-5.4% | 5.61 |
| Other Income | 0.34+359.6% | 0.07+101.1% | 0.04-11.8% | 0.04-96.7% | 1.25+1239.8% | 0.09+200.0% | 0.03 |
| Total Income | 5.47+42.0% | 3.85-25.3% | 5.16+6.6% | 4.84-7.4% | 5.22-3.4% | 5.40-4.3% | 5.64 |
| EXPENSES | |||||||
| Expenditure | 4.60+3.2% | 4.46-8.9% | 4.90+2.7% | 4.77-6.9% | 5.12-2.4% | 5.24-5.3% | 5.54 |
| Tax | 0.30+168.9% | -0.44-275.1% | 0.25+417.3% | 0.05+197.0% | -0.05-146.4% | 0.11+6.9% | 0.10 |
| PROFIT | |||||||
| PBT | 0.87+242.4% | -0.61-333.5% | 0.26+273.5% | 0.07-31.5% | 0.10-36.8% | 0.16+49.1% | 0.11 |
| Net Profit | 0.56+435.4% | -0.17-1984.3% | 0.01-57.8% | 0.02-86.1% | 0.15+192.1% | 0.05+642.9% | 0.01 |
| KEY METRICS | |||||||
| OPM % | 19.53%+26.72pp | -7.19%-20.77pp | 13.58%+2.94pp | 10.64%+29.48pp | -18.84%-11.96pp | -6.88%-0.09pp | -6.79% |
| NPM % | 10.29%+14.65pp | -4.36%-4.53pp | 0.17%-0.27pp | 0.44%-2.47pp | 2.91%+1.95pp | 0.96%+0.84pp | 0.12% |
| EPS | 1.11+236.4% | 0.33+1550.0% | 0.02-50.0% | 0.04-86.7% | 0.30+200.0% | 0.10+900.0% | 0.01 |
Corporate Events
Board MeetingBERLDRG
202628May
Board Meeting
To consider and approve the Audited Financial Statement incl…
BSE Filing ↗ Board MeetingBERLDRG
20261Apr
Board Meeting
To consider and approve the date and notice of an Extra Ordi…
BSE Filing ↗ Board MeetingBERLDRG
202530May
Board Meeting
Consider & approve Audited Financial Results, take on record…
BSE Filing ↗ Board MeetingBERLDRG
202413Nov
Board Meeting
Consider Unaudited Financial Results (UFR Q2) and Limited Re…
BSE Filing ↗ Board MeetingBERLDRG
20243Sep
Board Meeting
Consider and approve the Board report and other matters rela…
BSE Filing ↗